Moreover, the proportions of patients within each risk category may vary between studies, making one trial drug seem more effective ... 250 mg/dL), 412 patients received rosuvastatin 5 mg ...

rosuvastatin 10-40 mg, ER niacin 0.5-2 g, rosuvastatin 40 mg plus ER niacin 0.5-1 g, or rosuvastatin 10 mg plus ER niacin 0.5-2 g. Daily doses of rosuvastatin 40 mg monotherapy reduced low-density ...